2
Views
2
CrossRef citations to date
0
Altmetric
 

ABSTRACT

Spielberger State and Trait anxiety scores are reported for 378 cancer patients and 379 matched relatives. Anxiety scores are given by demographic and clinical characteristics. Analysis of variance with the Scheffe procedure indicates but one substantive distinguishing characteristic: treatment status. Patients receiving palliative care displayed significantly higher anxiety scores than did patients under active treatment or follow-up care. Correlations between patients’ state and trait scores increased according to whether patients were receiving follow-up, active, or palliative care. The correlation between state and trait scores for patients under palliative care (r = .78) is so high as to suggest that the measures of state (transient) and trait (permanent) mood status are essentially identical. The high level of anxiety displayed by patients under palliative treatment suggests the need for intervention such as that provided by hospice care, and indicates that anti-anxiety medication may be underutilized.

Additional information

Notes on contributors

Barrie R. Cassileth

All authors are affiliated with the University of Pennsylvania Cancer Center, where B. Cassileth, PhD, is Director of Psychosocial Programs, E. Lusk, PhD, Director of Biostatistics, and W. Walsh, MA, Senior Psychosocial Programs Research Coordinator.

Edward J. Lusk

All authors are affiliated with the University of Pennsylvania Cancer Center, where B. Cassileth, PhD, is Director of Psychosocial Programs, E. Lusk, PhD, Director of Biostatistics, and W. Walsh, MA, Senior Psychosocial Programs Research Coordinator.

William P. Walsh

All authors are affiliated with the University of Pennsylvania Cancer Center, where B. Cassileth, PhD, is Director of Psychosocial Programs, E. Lusk, PhD, Director of Biostatistics, and W. Walsh, MA, Senior Psychosocial Programs Research Coordinator.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.